Clinical Trial

Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma

Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
In this study, the investigators evaluate the potential efficacy of TXA alone and microneedling assisted with glutathione alone versus combination of oral tranexamic acid and glutathione-assisted microneedling in the treatment of melasma
Trial Details
NCT Number NCT07448415
Lead Sponsor Assiut University
Conditions Melasma
Enrollment 42 participants
Start Date 2026-02
Primary Completion 2027-02 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-04